The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays.
Ellis SlotmanK SchreuderT E C NijstenM WakkeeL HollesteinA MooyaartS SieslingM W J LouwmanPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Diagnosis of keratinocyte carcinoma was suboptimal during the COVID-19 pandemic, due to diagnostic delays likely resulting from both patient and health system-related delay. Further studies will need to determine the effects of these diagnostic delays on outcomes.